The increased resistance of glioma cells expressing NG2 to chemo- and radiation therapy has been attributed to the cis-interaction of NG2 with α3β1-Integrin (via the ß-1 subunit) which activates the PI3K/Akt signal pathway [12]. This evidence concerns the gene CSPG4 and glioma.